INGR - Ingredion's Growth Strategy To Please Health-Conscious Consumers Can Make It A Winner: Analyst | Benzinga
Oppenheimer analyst Kristen Owen initiated coverage on Ingredion Inc (NYSE: INGR) with an Outperform rating and a price target of $120.
The analyst believes Ingredion's investments in sugar reduction, plant-based protein, and specialty texturizers bode well with consumer's focus on health and wellness and mindful eating. This underpins the company's migration to specialty from commodity, thereby driving ROIC.
The analyst sees revenue diversification, enhancing ...